The Outcomes of Percutaneous RevascularizaTIon for Management of SUrgically Ineligible Patients With Multivessel or Left Main Coronary Artery Disease (OPTIMUM) Registry: Rationale and Design

Authors:

Abstract
No abstract available
Funding Information
  • Boston Scientific Corporation (ISROTH10299)
  • Abbott Vascular
  • Cardiovascular Systems
  • Biotronik
  • Medtronic

This publication has 38 references indexed in Scilit: